Matthew Pase

Matthew Pase is an Associate Professor at Monash University, leading the Epidemiology of Dementia Lab, the Aging and Neurodegeneration Research Program at the School of Psychological Science, and the Aging Well Pillar at the Turner Institute. He holds an adjunct position as Associate Professor of Epidemiology at Harvard University and has conducted postdoctoral training at the Framingham Heart Study and Boston University School of Medicine.

Education:

• PhD in Neuropsychology/Neuroscience (2014), specializing in modifiable hemodynamic predictors of cognitive aging

Research focuses on modifiable risk factors for dementia, validation of non-invasive biomarkers, and sleep-dementia relationships. Notable projects include the Brain and Cognitive Health (BACH) cohort, NIH-funded Sleep and Dementia Consortium, and the Vascular Contributions to Dementia (VCD-CRE) initiative.

Key themes in recent articles include sleep architecture’s impact on dementia risk, neurovascular integrity in aging, and biomarkers like YKL-40 and plasma tau. His work emphasizes translational research to reduce cognitive disorder burdens.

Grants/Projects:

• ARC Training Centre for Optimal Ageing (2023–2028)
• Poor Sleep and Hypertension combined Alzheimer’s risk (2023–2025)
• Vascular Contributions to Dementia (2022–2027)

Labs/Teams: Leads multi-institutional collaborations, including the Framingham Heart Study and International Stroke Genetics Consortium’s Cognitive Working Group.